US EditionThe Royal Marsden NHS Foundation Trust Takes Advantage of AI to Push the Limits of Cancer Research Through NTT DATA and CARPL.ai – Global Security Mag Online
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.3 Articles
3 Articles
Global Security Mag Online
Global Security Mag OnlineThe Royal Marsden NHS Foundation Trust, one of the world's most renowned specialized oncology and cancer centres, announces a partnership with NTT DATA, a leading provider of IT infrastructure and services, and CARPL.ai, a leading platform in the field of artificial intelligence (IA) and machine learning (MLops) operations applied to corporate imaging. These three actors jointly designed and developed an advanced radiographic analysis service po…
World-leading cancer centre, The Royal Marsden NHS Foundation Trust, using AI to push boundaries of cancer research with NTT DATA and CARPL.ai
The Royal Marsden NHS Foundation Trust, the specialist cancer centre, has entered into a partnership with NTT DATA, the provider of digital business and technology services, and CARPL.ai, the enterprise imaging artificial intelligence (AI) and machine learning operations (MLOps) platform.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
